Platform Technologies Related to Oncology, Rare Genetic and Haematological Disease, and Medicinal Chemistry
Takeda Pharmaceutical are launching an open innovation initiative inviting researchers to submit their proposals addressing emerging technological platforms related to oncology, rare genetic or haematological disease, or medicinal chemistry. One‑year projects will be funded up to JPY 5,000,000 or equivalent amount, including indirect costs.
Projects should address one of four areas:
REF#6 Translational research platforms for immuno-oncology. Specifically: (i) translationally-relevant humanised animal models and/or in vitro/ex vivo tumour organoid systems...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile